Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The direct-to-consumer laboratory testing market was valued at USD 15.72 Billion in 2025. It is poised to grow at a CAGR of 26.80% during the forecast period of 2026-2035, and reach USD 168.91 Billion by 2035. The market growth is driven by the increasing consumer preference for DTC lab test services, home collection kits, and online blood tests, driving market growth, enabling convenient self-ordered diagnostics and personalized health insights
Base Year
Historical Period
Forecast Period
In January 2026, OraSure Technologies submitted FDA applications for a rapid molecular self-test for STIs and an at-home urine collection device, expanding access and accelerating DTC testing adoption.
In February 2026, a study in Communications Biology evaluated direct-to-consumer gut microbiome tests, showing growing consumer usage, improving test accuracy, and supporting broader adoption of biomarker panel diagnostics.
In January 2026, a STAT report noted more Americans ordering lab tests online for personal health insights, challenging traditional care models. This surge in direct ordering is expected to reinforce adoption of digital health services and strengthen growth in the forecast period.
Compound Annual Growth Rate
26.8%
Value in USD Billion
2026-2035
*this image is indicative*
The market is expanding rapidly, driven by growing demand for DTC lab test services, home collection kits, and self-ordered diagnostics. Consumers increasingly prefer convenient online access to wellness testing, STI testing, and biomarker panels. Rising awareness of health monitoring, coupled with digital platforms offering subscription lab testing and CBC test online, is accelerating market adoption and growth globally. The market reached a value of approximately USD 15.72 Billion in 2025.
Increasing Access to At Home Diagnostic Testing Solutions to Propel the Market Demand
Growing consumer demand for convenient STI testing and privacy focused diagnostics, along with rising telehealth uptake and home sample collection services, is driving market growth. For instance, in January 2026, OraSure Technologies submitted FDA applications for a rapid molecular self test for STIs and an at home urine collection device, expanding consumer access and expected to accelerate adoption of direct to consumer testing solutions in the forecast period.
Key trends shaping the market include rising adoption of DTC lab test, self ordered diagnostics, home collection kits, online blood tests, biomarker panels, and subscription lab testing.
Rising Integration of Telehealth Platforms to Boost the Market Expansion
The increasing integration of telehealth platforms with direct-to-consumer (DTC) laboratory testing is emerging as a significant trend shaping the market landscape. For instance, in November 2025, Hims & Hers partnered with Quest Diagnostics to introduce DTC lab testing services, enabling consumers to independently access diagnostic tests and identify potential health risks. This trend is expected to enhance accessibility, streamline care delivery, and accelerate the adoption of consumer-centric diagnostic solutions across the market.
Market Breakup by Sample Type
Market Breakup by Test Type
Market Breakup by Distribution Channel
Market Breakup by End User
Market Breakup by Region
Saliva Expected to Dominate the Market Share by Sample Type
Saliva samples accounted for over 46% of the market share in the historical period. The widespread availability of home collection kit services enabled consumers to collect samples conveniently at home and access results online. This trend demonstrates increasing adoption of self-directed testing solutions, enhancing accessibility, convenience, and consumer engagement, supporting market growth during the forecast period.
North America held approximately 39% share in the historical period, driven by advanced healthcare infrastructure, digital platforms, and widespread consumer awareness. The region’s extensive adoption of online blood test services allows individuals to access personalized testing and health insights remotely. This adoption trend reinforces North America’s leadership and is expected to sustain market dominance throughout the forecast period.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
LabCorp Holdings Inc., headquartered in Burlington, North Carolina, was established in 1978. It provides extensive diagnostic services and DTC lab test options through consumer initiated testing services, enabling customers to order tests online and receive results via secure portals, expanding access to personalized diagnostics. LabCorp’s strong brand and broad test portfolio support consumer autonomy in health management.
Quest Diagnostics, headquartered in Secaucus, New Jersey, was established in 1967 and is a major clinical laboratory services provider in the US and abroad. Quest offers a range of diagnostics including online blood tests and consumer accessible services such as self ordered diagnostics via QuestDirect, letting individuals order and manage CBC test online and other lab tests without physician referrals.
Everlywell is a direct to consumer health testing company founded in 2014 and based in Austin, Texas. It offers home collection kit services that let users collect samples at home and access lab results online for wellness, hormone, and sexual health tests. In March 2026, Everlywell expanded access to a gut microbiome test through a partnership with Jona, enhancing its portfolio of consumer focused diagnostics.
LetsGetChecked, co headquartered in Dublin, Ireland, and New York, USA, was founded in 2015 and delivers at home health testing and telehealth services. It enables individuals to order confidential health assessments, including wellness testing and infectious disease panels, from anywhere. In January 2025, the company secured USD 165 million funding to expand its end to end testing and care offerings globally, strengthening its consumer focused diagnostics presence.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are HealthTap, AncestryDNA, Veritas Genetics, MyHeritage, Color Genomics, Helix, Orig3n, Pathway Genomics, Thermo Fisher Scientific, Genome Medical, and HealthCheck.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Sample Type |
|
| Breakup by Test Type |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share